Relative Sensitivity of Fine Needle Aspiration by Tumor Type and Size
Andrew A Renshaw, Vickie Y Jo, Jeffrey F Krane. Baptist Hospital of Miami, Miami, FL; Brigham and Women's Hospital & Harvard Medical School, Boston, MA
Background: Fine-needle aspiration (FNA) of papillary thyroid carcinoma has overall high sensitivity. Previous studies have shown correlation between FNA sensitivity and size of papillary thyroid carcinoma, and lower sensitivity for follicular variant of papillary carcinoma. Data on other types of thyroid carcinomas are lacking.
Design: We reviewed the results of 997 resected thyroid carcinomas at two institutions (5/1/2005 - 8/2011; 1/1999 to 11/2009), and correlated the findings with clinical and cytologic information. FNA diagnoses were classified according to The Bethesda System for Reporting Thyroid Cytopathology, and FNA diagnoses of "Malignant", "Suspicious for Malignancy", and "Suspicious for Follicular/Oncocytic Neoplasm" were considered "positive". Overall sensitivity of FNA and sensitivities based on size groups (≤1.0 cm, 1-3 cm, ≥3.0 cm) were calculated using "positive" FNAs as the numerator for each malignancy type.
Results: There were 868 papillary carcinomas (including 371 follicular variants), 101 follicular carcinomas (including 31 oncocytic variants), 16 medullary carcinomas, and 12 poorly differentiated carcinomas. The mean size of classical papillary carcinoma (1.9 cm, range 0.3-6.5 cm) was significantly smaller than for follicular variant of papillary carcinoma (2.2 cm, range 0.3-9.5 cm), follicular carcinoma, oncocytic variant (3.0 cm, range 0.4-10.0 cm), follicular carcinoma (3.0 cm, range 0.6-9.5 cm), and poorly differentiated carcinoma (2.8 cm, range 1.2-6.4 cm) (p < 0.003 for each), but not for medullary carcinoma (1.7 cm, range 0.6-3.3 cm) (p = 0.45). FNA sensitivities based on size groups are shown in Table 1.
|≤1.0 cm||1-3 cm||≥3.0 cm||Overall Sensitivity|
|Follicular Variant of Papillary Carcinoma||74%||79%||77%||78%|
|Follicular Carcinoma, Oncocytic Variant||50%||83%||100%||84%|
|Poorly Differentiated Carcinoma||N/A||100%||100%||100%|